0000873303-14-000030.txt : 20140304
0000873303-14-000030.hdr.sgml : 20140304
20140304210032
ACCESSION NUMBER: 0000873303-14-000030
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20140228
FILED AS OF DATE: 20140304
DATE AS OF CHANGE: 20140304
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Sarepta Therapeutics, Inc.
CENTRAL INDEX KEY: 0000873303
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 930797222
STATE OF INCORPORATION: MA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 215 FIRST STREET
STREET 2: SUITE 7
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
BUSINESS PHONE: 857-242-3700
MAIL ADDRESS:
STREET 1: 215 FIRST STREET
STREET 2: SUITE 7
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
FORMER COMPANY:
FORMER CONFORMED NAME: Sarepta Therapuetics, Inc.
DATE OF NAME CHANGE: 20120712
FORMER COMPANY:
FORMER CONFORMED NAME: AVI BIOPHARMA INC
DATE OF NAME CHANGE: 19980930
FORMER COMPANY:
FORMER CONFORMED NAME: ANTIVIRALS INC
DATE OF NAME CHANGE: 19970123
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Wigzell Hans Lennart Rudolf
CENTRAL INDEX KEY: 0001492766
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-14895
FILM NUMBER: 14667185
MAIL ADDRESS:
STREET 1: OSKAR BAECKSTROMSV.11
CITY: HAGERSTEN
STATE: V7
ZIP: 12935
4
1
edgardoc.xml
PRIMARY DOCUMENT
X0306
4
2014-02-28
0
0000873303
Sarepta Therapeutics, Inc.
SRPT
0001492766
Wigzell Hans Lennart Rudolf
215 FIRST STREET, SUITE 7
CAMBRIDGE
MA
02142
1
0
0
0
Common Stock
2014-02-28
4
A
0
1000.0
0.0
A
3666
D
Non-Qualified Stock Option (right to buy)
29.03
2014-02-28
4
A
0
15000.0
0.0
A
2024-02-28
Common Stock
15000
15000
D
This is a Restricted Stock Award that will vest at a rate of 25% annually over four years to commence on the first anniversary of the Issuers next annual meeting of stockholders.
This option will vest at a rate of 25% annually over four years to commence on the first anniversary of the Issuers next annual meeting of stockholders.
By: /s/David Tyronne Howton For: Hans Lennart Rudolf Wigzell
2014-03-04